Comparing of Titan Pharmaceuticals Inc. (TTNP) and Teligent Inc. (NASDAQ:TLGT)

Titan Pharmaceuticals Inc. (NASDAQ:TTNP) and Teligent Inc. (NASDAQ:TLGT) compete with each other in the Biotechnology sector. We will analyze and contrast their risk, analyst recommendations, profitability, dividends, earnings and valuation, institutional ownership.

Earnings & Valuation

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Titan Pharmaceuticals Inc. 6.50M 2.93 11.22M -2.24 0.00
Teligent Inc. 64.44M 0.46 40.18M -0.75 0.00

Table 1 shows the gross revenue, earnings per share (EPS) and valuation for Titan Pharmaceuticals Inc. and Teligent Inc.

Profitability

Table 2 provides us Titan Pharmaceuticals Inc. and Teligent Inc.’s return on equity, return on assets and net margins.

Net Margins Return on Equity Return on Assets
Titan Pharmaceuticals Inc. -172.62% -366.4% -103.8%
Teligent Inc. -62.35% -84.1% -14.9%

Volatility and Risk

Titan Pharmaceuticals Inc. has a 0.62 beta, while its volatility is 38.00%, thus making it less volatile than Standard and Poor’s 500. Teligent Inc.’s 1.45 beta is the reason why it is 45.00% more volatile than Standard and Poor’s 500.

Liquidity

3.9 and 3.5 are the respective Current Ratio and a Quick Ratio of Titan Pharmaceuticals Inc. Its rival Teligent Inc.’s Current and Quick Ratios are 1.5 and 1 respectively. Titan Pharmaceuticals Inc. has a better chance of clearing its pay short and long-term debts than Teligent Inc.

Insider & Institutional Ownership

Titan Pharmaceuticals Inc. and Teligent Inc. has shares held by institutional investors as follows: 4.6% and 83.8%. 4.32% are Titan Pharmaceuticals Inc.’s share held by insiders. Competitively, 0.1% are Teligent Inc.’s share held by insiders.

Performance

In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Titan Pharmaceuticals Inc. 3.64% 0% 6.21% -28.86% -66.07% 27.8%
Teligent Inc. -0.89% -10.79% -43.54% -72.55% -69.96% -34.88%

For the past year Titan Pharmaceuticals Inc. has 27.8% stronger performance while Teligent Inc. has -34.88% weaker performance.

Summary

Teligent Inc. beats Titan Pharmaceuticals Inc. on 6 of the 10 factors.

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on treatments for chronic diseases. The company offers Probuphine, a product candidate for maintenance treatment of opioid dependence, which maintains a stable, around the clock blood level of the drug buprenorphine in patients for six months following a single treatment. It also develops ProNeura-Ropinirole, an implant to provide delivery of ropinirole, a dopamine agonist for the treatment of Parkinson's disease; and triiodothyronine, an implant for the treatment of hypothyroidism. The company has a collaboration with Nevada Center for Behavioral Health to evaluate a medication-assisted treatment program utilizing Probuphine (buprenorphine) implant for Opioid Use Disorder (OUD) patients. Titan Pharmaceuticals, Inc. was founded in 1992 and is based in South San Francisco, California.

Teligent, Inc., a specialty generic pharmaceutical company, develops, formulates, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. It also develops, manufactures, fills, and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets. The companyÂ’s products are used in various applications that range from cosmetics and cosmeceuticals to the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. In addition, it offers contract formulation and contract manufacturing services comprising formulating, testing, and/or manufacturing prescription drugs and medical devices. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.